Witz Pascale
SEC insider (Form 3/4/5 filer). CIK 0001703723. Director at REVVITY, INC. (RVTY) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in WALTHAM, MA.
Companies Witz Pascale has filed insider reports for
- REVVITY, INC. (RVTY): Director
- Regulus Therapeutics Inc. (RGLS): Director
Witz Pascale
CIK: 0001703723
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (83.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (16.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 7, 2026RVTY
REVVITY, INC.
AwardDirect1K shares- - May 7, 2026RVTY
REVVITY, INC.
AwardDirect1.3K shares- - Jun 25, 2025RGLS
Regulus Therapeutics Inc.
DispositionDirect67.2K shares- - Apr 30, 2025RVTY
REVVITY, INC.
AwardDirect1.1K shares- - Apr 30, 2025RVTY
REVVITY, INC.
AwardDirect1.3K shares- - Apr 30, 2025RGLS
Regulus Therapeutics Inc.
AwardDirect62.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 7, 2026 |  RVTY REVVITY, INC. | Award | 1,015 | - | $0 | Direct |
| May 7, 2026 | RVTY REVVITY, INC. | Award | 1,265 | - | $0 | Direct |
| Jun 25, 2025 |  RGLS Regulus Therapeutics Inc. | Disposition | 67,233 | - | - | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award | 1,074 | - | - | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award | 1,338 | - | - | Direct |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | Award | 62,500 | - | - | Direct |
1-6 of 6 transactions